枸橼酸西地那非和戊酸雌二醇作为枸橼酸氯米芬辅助卵巢刺激周期辅助剂对不明原因不孕症患者的疗效比较:双盲随机对照试验。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY
Jean-Didier Bosenge-Nguma, Antoine Modia O'yandjo, Roland Marini Djang'eing'a, Juakali Skv, Noël Labama Otuli, Justin Kadima Ntokamunda, Alexis Heng Boon Chin, Gédéon Katenga Bosunga
{"title":"枸橼酸西地那非和戊酸雌二醇作为枸橼酸氯米芬辅助卵巢刺激周期辅助剂对不明原因不孕症患者的疗效比较:双盲随机对照试验。","authors":"Jean-Didier Bosenge-Nguma, Antoine Modia O'yandjo, Roland Marini Djang'eing'a, Juakali Skv, Noël Labama Otuli, Justin Kadima Ntokamunda, Alexis Heng Boon Chin, Gédéon Katenga Bosunga","doi":"10.1186/s40834-024-00307-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the effect of sildenafil citrate and estradiol valerate as adjuvant therapy during ovarian stimulation cycles with clomiphene citrate in patients with unexplained infertility in Kisangani.</p><p><strong>Method: </strong>A double-blind, randomized controlled trial was conducted for two years at two specialized health facilities in Kisangani (University Clinics of Kisangani and \"Clinique des Anges Kisangani\"). The population included 148 patients, 74 of whom were on clomiphene citrate + sildenafil citrate (CCSC) regimens and 74 of whom were on clomiphene citrate + estradiol valerate (CCEV) regimens for three months. The primary indicator was the conception rate, with secondary outcomes encompassing endometrial thickness, appearance and vascularity, the number of mature follicles and ovulation rate.</p><p><strong>Results: </strong>The two groups were comparable in terms of sociodemographic and clinical characteristics. The mean duration of attempting to conceive was 4.39 years versus 4.36 years (P = 0.839), while the mean AFC was 11.51 versus 11.46 (P = 0.831), in the CCSC group versus CCEV group respectively. Secondary infertility was the most frequent diagnosis in each of the two groups. The biochemical pregnancy rate was comparable between the two groups (P = 0.385), while the clinical pregnancy rate was significantly higher in the CCSC group versus CCEV group (P = 0.04). Both perifollicular flow and the ovulation rate were significantly higher in the CCSC group versus the CCEV group (P = 0.006 and P = 0.002 respectively). However, endometrial vascularity/thickness, and the number of Graafian follicles were not significantly different between the two groups.</p><p><strong>Conclusion: </strong>As an adjuvant, sildenafil increases the rate of clinical pregnancy more than does estradiol in patients with unexplained infertility undergoing ovarian stimulation with clomiphene citrate.</p><p><strong>Study registration: </strong>PACTR 202,310,849,449,401 (Pan African Clinical Trials Registry).</p>","PeriodicalId":93956,"journal":{"name":"Contraception and reproductive medicine","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462857/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative effectiveness of sildenafil citrate and estradiol valerate as adjuvants during clomiphene citrate-assisted ovarian stimulation cycles in patients with unexplained infertility: a double-blind randomized controlled trial.\",\"authors\":\"Jean-Didier Bosenge-Nguma, Antoine Modia O'yandjo, Roland Marini Djang'eing'a, Juakali Skv, Noël Labama Otuli, Justin Kadima Ntokamunda, Alexis Heng Boon Chin, Gédéon Katenga Bosunga\",\"doi\":\"10.1186/s40834-024-00307-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aimed to assess the effect of sildenafil citrate and estradiol valerate as adjuvant therapy during ovarian stimulation cycles with clomiphene citrate in patients with unexplained infertility in Kisangani.</p><p><strong>Method: </strong>A double-blind, randomized controlled trial was conducted for two years at two specialized health facilities in Kisangani (University Clinics of Kisangani and \\\"Clinique des Anges Kisangani\\\"). The population included 148 patients, 74 of whom were on clomiphene citrate + sildenafil citrate (CCSC) regimens and 74 of whom were on clomiphene citrate + estradiol valerate (CCEV) regimens for three months. The primary indicator was the conception rate, with secondary outcomes encompassing endometrial thickness, appearance and vascularity, the number of mature follicles and ovulation rate.</p><p><strong>Results: </strong>The two groups were comparable in terms of sociodemographic and clinical characteristics. The mean duration of attempting to conceive was 4.39 years versus 4.36 years (P = 0.839), while the mean AFC was 11.51 versus 11.46 (P = 0.831), in the CCSC group versus CCEV group respectively. Secondary infertility was the most frequent diagnosis in each of the two groups. The biochemical pregnancy rate was comparable between the two groups (P = 0.385), while the clinical pregnancy rate was significantly higher in the CCSC group versus CCEV group (P = 0.04). Both perifollicular flow and the ovulation rate were significantly higher in the CCSC group versus the CCEV group (P = 0.006 and P = 0.002 respectively). However, endometrial vascularity/thickness, and the number of Graafian follicles were not significantly different between the two groups.</p><p><strong>Conclusion: </strong>As an adjuvant, sildenafil increases the rate of clinical pregnancy more than does estradiol in patients with unexplained infertility undergoing ovarian stimulation with clomiphene citrate.</p><p><strong>Study registration: </strong>PACTR 202,310,849,449,401 (Pan African Clinical Trials Registry).</p>\",\"PeriodicalId\":93956,\"journal\":{\"name\":\"Contraception and reproductive medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462857/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception and reproductive medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40834-024-00307-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception and reproductive medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40834-024-00307-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在评估枸橼酸西地那非和戊酸雌二醇作为枸橼酸氯米芬卵巢刺激周期辅助疗法对基桑加尼不明原因不孕症患者的影响:在基桑加尼的两家专业医疗机构(基桑加尼大学诊所和 "基桑加尼 Anges 诊所")进行了为期两年的双盲随机对照试验。研究对象包括 148 名患者,其中 74 人采用枸橼酸克罗米芬+枸橼酸西地那非(CCSC)方案,74 人采用枸橼酸克罗米芬+戊酸雌二醇(CCEV)方案,为期三个月。主要指标是受孕率,次要指标包括子宫内膜厚度、外观和血管、成熟卵泡数量和排卵率:两组在社会人口学和临床特征方面具有可比性。CCSC组和CCEV组的平均试孕时间分别为4.39年和4.36年(P = 0.839),平均AFC分别为11.51和11.46(P = 0.831)。继发性不孕是两组中最常见的诊断。两组的生化妊娠率相当(P = 0.385),而 CCSC 组的临床妊娠率明显高于 CCEV 组(P = 0.04)。CCSC组的卵泡周围流量和排卵率均明显高于CCEV组(分别为P = 0.006和P = 0.002)。然而,子宫内膜血管/厚度和格拉菲卵泡数量在两组间无明显差异:结论:对于接受枸橼酸氯米芬卵巢刺激的不明原因不孕症患者,西地那非作为辅助药物比雌二醇更能提高临床妊娠率:研究注册:PACTR 202,310,849,449,401(泛非临床试验注册)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative effectiveness of sildenafil citrate and estradiol valerate as adjuvants during clomiphene citrate-assisted ovarian stimulation cycles in patients with unexplained infertility: a double-blind randomized controlled trial.

Objective: This study aimed to assess the effect of sildenafil citrate and estradiol valerate as adjuvant therapy during ovarian stimulation cycles with clomiphene citrate in patients with unexplained infertility in Kisangani.

Method: A double-blind, randomized controlled trial was conducted for two years at two specialized health facilities in Kisangani (University Clinics of Kisangani and "Clinique des Anges Kisangani"). The population included 148 patients, 74 of whom were on clomiphene citrate + sildenafil citrate (CCSC) regimens and 74 of whom were on clomiphene citrate + estradiol valerate (CCEV) regimens for three months. The primary indicator was the conception rate, with secondary outcomes encompassing endometrial thickness, appearance and vascularity, the number of mature follicles and ovulation rate.

Results: The two groups were comparable in terms of sociodemographic and clinical characteristics. The mean duration of attempting to conceive was 4.39 years versus 4.36 years (P = 0.839), while the mean AFC was 11.51 versus 11.46 (P = 0.831), in the CCSC group versus CCEV group respectively. Secondary infertility was the most frequent diagnosis in each of the two groups. The biochemical pregnancy rate was comparable between the two groups (P = 0.385), while the clinical pregnancy rate was significantly higher in the CCSC group versus CCEV group (P = 0.04). Both perifollicular flow and the ovulation rate were significantly higher in the CCSC group versus the CCEV group (P = 0.006 and P = 0.002 respectively). However, endometrial vascularity/thickness, and the number of Graafian follicles were not significantly different between the two groups.

Conclusion: As an adjuvant, sildenafil increases the rate of clinical pregnancy more than does estradiol in patients with unexplained infertility undergoing ovarian stimulation with clomiphene citrate.

Study registration: PACTR 202,310,849,449,401 (Pan African Clinical Trials Registry).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信